Skip to content

Urologie

08/07/2022
Urologie

Urethro-venous fistula following straddle injury: A case report and image series.

PMID: 36016722 PMCID: PMC9396026 DOI: 10.1016/j.eucr.2022.102184dr. D'hulst Pieter
10/03/2022
Urologie

Irrigation fluid absorption syndrome during HoLEP: A case study.

Urol Case Rep. 2022 Oct 3;45:102248. doi: 10.1016/j.eucr.2022.102248. eCollection 2022 Nov. PMID: 36238443dr. Uvin Pieter
01/01/2020
Urologie

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy.

Future Oncol 16(16):1083-9.dr. Uvin Pieter
01/01/2020
Urologie

TRPV4 Mediates Acute Bladder Responses to Bacterial Lipopolysaccharides.

Front. Immunol 11 :799. Article DOI: 10.3389/fimmu.2020.00799.dr. Uvin Pieter
06/12/2023
Urologie

The Effect of Surgical Experience on Perioperative and Oncological Outcomes After Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Evidence from a Referral Centre with Extensive Experience in Robotic Surgery.

Eur Urol Focus, accepted 12 Feb 2020,(Epub ahead of print), Article DOI 10.1016/j.euf.2020.01.016.dr. Uvin Pieter
01/01/2020
Urologie

Lifestyle among urology trainees and young urologist in the context of burn-out syndrome.

Actas Urol Esp 44(1):19-26.dr. Uvin Pieter
05/01/2020
Urologie

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy.

Future Oncol. 2020 Jun;16(16):1083-1189. doi: 10.2217/fon-2020-0056. Epub 2020 May 1.Future Oncol. 2020. PMID: 32356465dr. Uvin Pieterdr. Ghysel Christophe
06/11/2019
Urologie

Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy.

Eur Urol Focus, accepted Jun 11 2019, (Epub ahead of print), Article DOI: 10.1016/j.euf.2019.05.015dr. Uvin Pieter
10/01/2019
Urologie

106PElevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer.

Annals of Oncology. 2019 Oct 1;30 (Supplement_5).dr. Ghysel Christophe
07/01/2019
Urologie

Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer.

JAMA Oncol. 2019 Jul 1;5(7):1060–2.dr. Ghysel Christophe
01/01/2018
Urologie

Chapter 38 : Robotic or Laparoscopic Renal Surgery: Pros and Cons. In: Hemal AK, Menon M. Robotics in Genitourinary Surgery.

Second Edition. ISBN: 978-3-319-20644-8. Springer International Publishing. Pagina’s 515-547.dr. Uvin Pieter
06/12/2023
Urologie

The use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: a prospective randomized cohort study.

Int J of Urol, accepted Nov 21 2018, (Epub ahead of print), Article DOI: 10.1111/iju.13883.dr. Uvin Pieter
01/01/2018
Urologie

Fatigue syndrome: Stress, Burnout and Depression in Urology.

Arch Esp Urol 71(1) :46-54.dr. Uvin Pieter
01/01/2018
Urologie

Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model.

Ther Adv Urol. 2018;10:213-221dr. Arentsen Harm
06/12/2023
Urologie

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.

Genome Medicine; 2018 Nov 16;:1–13.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe
09/12/2018
Urologie

TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer.

Clinical Cancer Research. 2018 Sep 12;clincanres.1943.2018.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe
05/01/2018
Urologie

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

Prostate. 2018 May;78(6):435–45.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe
06/12/2023
Urologie

Circulating tumour cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

Journal of Clinical Oncology. American Society of Clinical Oncology; 2017 May 20;35(15_suppl):5049–9.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe

12 maart 2024

Multidiscipliniaire aanpak van rectumkanker (niet gemetastaseerd)

29 februari 2024

Informatiedag omtrent gehoorverlies en hooroplossingen

29 februari 2024

Innovatieve behandelingen voor goedaardige prostaatvergroting

29 februari 2024

Multidiscipliniaire aanpak van rectumkanker (niet gemetastaseerd)